✨ Free AI Report
SYNLAB AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Company Research

SYNLAB AG: Business Overview, Financials & Competitive Analysis

SYNLAB AG scores 7/10 on the AskCyborg Cyborg Score (Strong). European diagnostics consolidator with market leadership, scale advantages, and exposure to growing specialty testing and precision medicine trends. SYNLAB commands a dominant market position in European diagnostics with substantial scale, recurring revenue from healthcare systems, and multiple growth vectors (emerging markets, genetic testing, precision medicine). Recent revenue decline reflects post-COVID.

What is SYNLAB AG's industry? SYNLAB AG (synlab.com) operates in Medical Diagnostics and Clinical Laboratory Services. AskCyborg classifies SYNLAB AG under Medical Diagnostics and Clinical Laboratory Services in its company registry.

SYNLAB is Europe's leading medical diagnostics provider, offering comprehensive laboratory services across clinical chemistry, microbiology, genetics, pathology and specialty testing. With operations in 36 countries a...

7/ 10Strong

Cyborg Score thesis

European diagnostics consolidator with market leadership, scale advantages, and exposure to growing specialty testing and...

Read the full analyst-debate transcript →
Industry Medical Diagnostics and Clinical Laboratory Services
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest SYNLAB AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for SYNLAB AG

AskCyborg analysts argue the bull and bear cases for SYNLAB AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
SYNLAB AG OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

SYNLAB AG Overview

Pro stress-test →

SYNLAB is Europe's leading medical diagnostics provider, offering comprehensive laboratory services across clinical chemistry, microbiology, genetics, pathology and specialty testing. With operations in 36 countries across four continents, the company processes 600 million samples annually through a network of approximately 500 laboratories and 1,800 blood collection points, generating €2.64 billion in revenue.

Strategic Profile

Pro stress-test →

SYNLAB differentiates through scale, geographic diversification, and a hub-and-spoke laboratory model enabling efficient cost management and specialized testing capabilities. The company pursues organic growth coupled with disciplined M&A, positioning itself as an industry consolidator in the fragmented European diagnostics market.

Competitive Landscape

Pro stress-test →

SYNLAB competes against laboratory networks and integrated diagnostic providers including Quest Diagnostics and LabCorp in the US market, and regional European players like Unilabs Group and Sonic Healthcare. SYNLAB's advantage lies in geographic concentration in Europe, integrated hub-and-spoke model, and scale across 30+ countries with 27,000+ employees.

Industry Context

SYNLAB AG operates in Medical Diagnostics and Clinical Laboratory Services.

Key facts

Founded: 1998 · Headquarters: Munich, Germany · Employees: 27000 · Revenue: €2.64B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on SYNLAB AG.

  • Delisted from Frankfurt Stock Exchange in July 2024 at its own request, raising questions about strategic direction and potential alternative ownership structure
  • Revenue declined 18.93% year-over-year in 2023 (€3.25B to €2.64B) following COVID-related PCR testing surge, normalizing growth trajectory
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • July 2024Delisted from German stock exchanges at own request
  • 2023Sold veterinary diagnostics segment to Mars Incorporated
  • +1 moreTrack every material event for SYNLAB AG as it happens. Explore monitoring →
Get alerted when SYNLAB AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare SYNLAB AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

SYNLAB AG operates in Medical Diagnostics and Clinical Laboratory Services. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Diagnostics and Clinical Laboratory Services research →
NEW · MCP server

Ask your AI assistant about SYNLAB AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare SYNLAB AG and its top competitor on Cyborg Score”
“What did SYNLAB AG do this quarter?”
“Is SYNLAB AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does SYNLAB AG do?+
SYNLAB is Europe's leading medical diagnostics provider, offering comprehensive laboratory services across clinical chemistry, microbiology, genetics, pathology and specialty testing. With operations in 36 countries a...
What is SYNLAB AG's Cyborg Score?+
SYNLAB AG has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are SYNLAB AG's main competitors?+
Named competitors include Quest Diagnostics, LabCorp, Unilabs Group. The full competitive landscape is in the AskCyborg report.
How can I get the full SYNLAB AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the SYNLAB AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track SYNLAB AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual